Recursion Pharmaceuticals, Inc. (RXRX)
3.42
-0.30
(-8.06%)
USD |
NASDAQ |
Feb 20, 16:00
3.44
+0.02
(+0.58%)
After-Hours: 20:00
Recursion Pharmaceuticals SG&A Expense (Quarterly) : 41.63M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 312.83M |
| Intellia Therapeutics, Inc. | 30.51M |
| XOMA Royalty Corp. | 9.734M |
| Mirum Pharmaceuticals, Inc. | 61.91M |
| Tango Therapeutics, Inc. | 8.924M |